Abstract
Introduction: As age advances, the risk of several noncommunicable diseases (NCDs) like diabetes, hypertension, heart disease,dyslipidemia, etc increases. Dementia is among the most common diseases of older adults and accounts for significant diseaseburden globally. Dyslipidemia is especially common in older adults with diabetes. In the current study, the aim was to assessif patients with dementia have dyslipidemia and if so, whether the frequency was different in age-matched control group.Material and methods: A total of 836 subjects over the age of 60 years were screened and of these, 536 (67.12 ± 4.5 years) subjectswho met the diagnostic criteria for diagnosis of dementia (Diagnostic and Statistical Manual-IV) were enrolled for the study. Atotal of 32 cognitively normal subjects above the age of 60 years, but without cardiovascular risk factors (65.12 ± 3.5 years) wereselected as controls. Selected patients underwent lipid profile assessment apart from detailed neuropsychological, neurological,and radiological examination. The frequency of dyslipidemia among cases and control was compared. Results: Totalserum cholesterol, very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL) in patients with dementia were234.56 ± 22.5 mg/dL, 136.58 ± 11.3 mg/dL, 35.5 ± 3.5 mg/dL, respectively, while high-density lipoprotein (HDL) was 28.7 ± 7.8mg/dL. Corresponding values in the healthy controls were: Total cholesterol (TC) = 156.36 ± 12.5 mg/dL, LDL = 86.15 ± 12.3mg/dL, VLDL = 25.5 ± 3.5 mg/dL, HDL = 37.7 ± 1.8 mg/dL. Comparison of means using paired t-test showed all biochemicalvalues (TC, LDL, VLDL, HDL) differed from controls (p < 0.0001). Out of 536 cases with dementia, 157 (29%) had deranged lipidprofile. Patients of Alzheimer's disease (AD) with comorbid diabetes and hypertension were more likely to have dyslipidemiacompared to AD patients without these two comorbidities (p < 0.05). Conclusion: The current study indicates that patientswith dementia have a high frequency of dyslipidemia, and the frequency is higher compared to healthy controls (p ≤ 0.05)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.